Remove Development Remove Drug Delivery Remove Drug Delivery Systems Remove Pharma Companies
article thumbnail

Prefilled syringes and vaccines: Optimising parenteral packaging for the next pandemic

Pharmaceutical Technology

When it comes to vaccines and other high-value biologics, it is essential that effective formulations go hand in hand with safe delivery. Cost is an important final factor, especially for small and mid-sized pharma companies. As such, NeoFlex plungers are ideal for highly sensitive, large molecule drugs. A new challenge

Packaging 130
article thumbnail

Quality first: How pharma can meet injectables demand while staying compliant

Pharmaceutical Technology

Several drug development trends are driving injectables demand. This includes the rising number of biologic drugs on the market, which are mostly administered parenterally. The injectable drugs market is currently valued at around $532 billion. This was higher than the number of approvals in 2019 and 2020.

article thumbnail

Top Emerging Therapies To Watch Out for in the Retinal Vein Occlusion Market

Delveinsight

Looking at the potential of the pipeline therapies they hold once approved, pharmaceutical companies are charting out a seemingly exciting course in the market. Therapies such as dexamethasone drug delivery system and vascular endothelial growth factor inhibitors have already pierced deeper into the market.